mailed
on 02 Aug 2024
Last Applicant/ Owned by
1 Adelaide Street East, Suite 801
Toronto, Ontario
CA
M5C2V9
Serial Number
98129120 filed on 11th Aug 2023
Registration Number
N/A
Correspondent Address
Maria A. Scungio
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Development of pharmaceutical preparations, pharmaceutical substances and pharmaceutical delivery systems; development of nutritional supplements, natural supplements, and dietary and nutritional supplements Vitamins; mineral supplements; Pharmaceutical preparations for the treatment of central nervous system and renal disorders, for activating cellular function, for enhancing cognitive function Read More
Development of pharmaceutical preparations, pharmaceutical substances and pharmaceutical delivery systems; development of nutritional supplements, natural supplements, and dietary and nutritional supplements
N/A
N/A
Custom manufacture of pharmaceutical preparations, pharmaceutical substances and pharmaceutical delivery systems; Custom manufacture of nutritional supplements, natural supplements, and dietary and nutritional supplements
N/A
N/A
Vitamins; mineral supplements; Pharmaceutical preparations for the treatment of central nervous system and renal disorders, for activating cellular function, for enhancing cognitive function and hangover relief; Nutritional supplements; dietary and nutritional supplements; herbal supplements; Natural nutritional
N/A
N/A
No 98129120
No Service Mark
No 33095.005
Yes
Yes
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
02th Aug 2024 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
02th Aug 2024 | SUSPENSION LETTER WRITTEN |
02th Aug 2024 | LETTER OF SUSPENSION E-MAILED |
15th Jul 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
15th Jul 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
15th Jul 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
15th Apr 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
15th Apr 2024 | NON-FINAL ACTION E-MAILED |
15th Apr 2024 | NON-FINAL ACTION WRITTEN |
11th Apr 2024 | ASSIGNED TO EXAMINER |